首页 | 官方网站   微博 | 高级检索  
     

结直肠癌术后患者异时性进展期腺瘤风险筛查模型的构建及验证
引用本文:结直肠癌术后患者异时性进展期腺瘤风险筛查模型的构建及验证.结直肠癌术后患者异时性进展期腺瘤风险筛查模型的构建及验证[J].首都医学院学报,2023,44(2):295-301.
作者姓名:结直肠癌术后患者异时性进展期腺瘤风险筛查模型的构建及验证
作者单位:1.首都医科大学附属北京世纪坛医院消化内科,北京,100038; 2.首都医科大学附属北京友谊医院消化内科,北京,100050
基金项目:北京市属医院科研培育项目(PX2021030),首都卫生发展科研专项 (2020-4-2085)
摘    要:目的 筛选结直肠癌术后患者发生异时性进展期腺瘤的危险因素,构建个体化风险筛查模型并验证模型的筛查效果。方法 将2007年4月至2017年10月行结直肠癌根治术的734例患者分为建模组和验证组,术后3年结肠镜随访。建模组采用单因素及多因素Logistic回归分析,建立风险筛查模型。利用验证组验证模型的筛查效果。结果 734例患者包括建模组485例,验证组249例。平均年龄为(64.6±11.5)岁,男性440例,女性294例。总的异时性进展期腺瘤发生率为11.9%(建模组12.0%,验证组11.6%)。多因素Logistic回归分析显示,男性、糖尿病病史、右半结肠癌、中低分化腺癌、腺癌合并腺瘤,腺癌合并进展期腺瘤为异时性进展期腺瘤的独立预测因素。根据Logistic多因素分析结果,建立筛查结直肠癌术后出现异时性进展期腺瘤的模型,并建立风险筛查列线图。受试者工作特征(receiver operating characteristic, ROC)曲线分析结果显示,该模型的受试者工作特征曲线下面积(area under the curve, AUC)=0.957(95%CI:0.935~0.9...

关 键 词:结直肠癌  异时性进展期腺瘤  筛查模型  验证
收稿时间:2022-09-26

Design and verification of screening model of metachronous advanced adenoma for postoperative colorectal cancer patients
Guo Chunmei,Liu Hong,Jiao Yue,Zhang Qian,Wang Canghai,Wang Yadan,Lin Wu,Wei Nan,Zhang Shutian,Wu Jing.Design and verification of screening model of metachronous advanced adenoma for postoperative colorectal cancer patients[J].Journal of Capital University of Medical Sciences,2023,44(2):295-301.
Authors:Guo Chunmei  Liu Hong  Jiao Yue  Zhang Qian  Wang Canghai  Wang Yadan  Lin Wu  Wei Nan  Zhang Shutian  Wu Jing
Affiliation:1. Gastroenterology Department, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China;      2. Gastroenterology Department, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China
Abstract:Objective To analysis the potential risk factors for metachronous advanced adenoma (MAA) in postoperative colorectal cancer (CRC) patients, so as to develop an individual surveillance scheme and verify it. Methods Totally 734 CRC patients who underwent surgery from April 2007 to October 2017 were divided into derivation group and validation group, and underwent surveillance colonoscopy for 3 years. Univariate and multivariate logistic analysis were conducted to establish screening model, and verify it in validation group. Results Totally 734 patients (male/female: 440/294) were finally included. The average age was (64.6 ±11.5) years, and the overall MAA incidence was 11.9% (12.0% in derivation group and 11.6% in validation group). Male, diabetes mellitus, right-sided colon cancer, moderately and poorly differentiated adenocarcinoma, synchronous adenoma, synchronous advanced adenoma were independent risk factors for MAA. According to the results of multivariate logistic analysis, MAA screening model and nomogram were established. The area under the curve (AUC) of MAA screening model was 0.957(95% CI: 0.935-0.973), and critical value was 0.938 7. External validation showed that the sensitivity was 93.1%, specificity was 89.1%, and the consistency between screening results and actual results was high (Kappa=0.62). Conclusions The screening model of metachronous advanced adenoma for postoperative CRC patients was constructed based on seven factors: male, diabetes history, right-sided colon cancer, moderately and poorly differentiated adenocarcinoma, synchronous adenoma, and synchronous advanced adenoma. It had high authenticity and consistency with actual results, and showed clinical application value.
Keywords:
点击此处可从《首都医学院学报》浏览原始摘要信息
点击此处可从《首都医学院学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号